Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Skin Cancer01:30

Skin Cancer

4.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

High-sensitivity X-ray imaging based on cost-effective and large-size CZT epitaxial crystal.

Materials horizons·2026
Same author

Development and Internal Validation of a Machine Learning-Based Classification Model for Identifying Cognitive Frailty in Older Inpatients with Type 2 Diabetes Mellitus.

Clinical interventions in aging·2026
Same author

Two Fatty Acids From Host Plant Leaves Are Attractive to Soritia leptatina Adults.

Journal of chemical ecology·2026
Same author

Predicting adolescent suicidal tendency in Chinese secondary school students: a machine learning approach with XGBoost and SHAP interpretation.

BMC public health·2026
Same author

Autophagy and multimodal programmed cell death and their crosstalk in ulcerative colitis.

Tissue & cell·2026
Same author

Interpretable machine learning-driven optimization of physicochemical properties in hydrogel scaffolds to promote macrophage polarization.

Biomaterials translational·2026

相关实验视频

Updated: Sep 10, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

在黑色素瘤中进行免疫治疗

Yan Xing1, Helena T Wu2,3, Swapnil Rajurkar3

  • 1City of Hope Comprehensive Cancer Center, Duarte, CA, USA. yxing@coh.org.

Cancer treatment and research
|August 23, 2025
PubMed
概括

皮肤黑色素瘤的全身治疗,包括免疫疗法和向疗法,可以改善新辅助,辅助和第四阶段的生存率. 根据疾病阶段和BRAF突变状态进行治疗选择.

关键词:
辅助剂BRAF 突变达布拉芬尼免疫疗法伊皮利穆马布黑色素瘤新辅助剂尼沃卢马布第四阶段黑色素瘤针对性的治疗

更多相关视频

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.1K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.8K

相关实验视频

Last Updated: Sep 10, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.1K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.8K

科学领域:

  • 癌症学
  • 皮肤病学
  • 免疫疗法

背景情况:

  • 皮肤黑色素瘤的治疗与全身疗法有显著的进化.
  • 了解不同疾病阶段的最佳策略对于患者的结果至关重要.

研究的目的:

  • 审查目前皮肤黑色素瘤的全身治疗策略.
  • 讨论新辅助,辅助和第四阶段的治疗方法.
  • 为了突出有效性,毒性和新兴疗法.

主要方法:

  • 对皮肤黑色素瘤的全身治疗方法的审查.
  • 在新辅助,辅助和转移环境中分析治疗方法.
  • 包括免疫检查点抑制剂和向治疗的数据.

主要成果:

  • 使用尼沃卢马布加上伊皮利穆马布的新辅助疗法显示出高反应率.
  • 辅助免疫疗法和向治疗改善了高风险黑色素瘤的无复发生存率.
  • 第四阶段的治疗使用基于BRAF状态的免疫疗法和MAPK途径抑制剂.

结论:

  • 系统疗法显著提高皮肤黑色素瘤的存活率和无治疗间隔.
  • 根据疾病阶段和分子标志物进行个性化治疗选择.
  • 瘤透性淋巴细胞等新兴疗法为未来的治疗提供了途径.